Go to CARVYKTI® (ciltacabtagene autoleucel) HCP homepage
  • About CARVYKTI®
    How CARVYKTI® works
    Manufacturing CARVYKTI®
  • CARVYKTI® Efficacy
    CARTITUDE-4
    Primary Analysis
    Study Design
    Progression-Free Survival (PFS)
    Overall Survival (OS)
    Depth of Response
    Duration of Response (DOR)
    CARTITUDE-4
    Follow-Up Analysis
    Progression-Free Survival (PFS)
    Overall Survival (OS)
    Depth of Response
    Duration of Response (DOR)
    Time to Next Treatment (TTNT)
    CARTITUDE-1
    Primary Analysis
    Study Design
    Depth of Response
    Duration of Response (DOR)
    Time to Response
    CARTITUDE-1
    5-Year Follow-Up Analysis
    5-Year Baseline Characteristics
    5-Year Duration of Response
  • CARVYKTI® Safety
    Boxed Warning
    Cytokine Release
    Syndrome (CRS)
    Neurologic Toxicities
    Hemophagocytic
    Lymphohistiocytosis (HLH)
    Prolonged and/or
    Recurrent Cytopenias
    Immune Effector Cell-Associated Enterocolitis
    Secondary Malignancies
    Additional Warnings & Precautions, and ARs ≥10%
    Safety Timeline/Long-Term Safety
  • Treatment Process
    Patient Identification
    Steps in the Treatment Process
  • Resources
    For Physicians
    For Nurses and APPs
    For Patients and Care Partners
    Patient Support Program
    For Access and Reimbursement Support
    For Order Management
  • Support for Nurses & APPs
  • Urgency to Treat Earlier
    Attrition Rates
    T-cell Fitness and Bridging Therapy
  • Treatment Centers
  • Coverage Lookup
  • Get In Touch
  • CARVYKTI® Prescribing Information
  • FAQs
  • Contact Us
  • Go To Patient Website
  • Prescribing Information
    CARVYKTI® PRESCRIBING INFORMATION
    CARVYKTI® LA INFORMACIÓN DE PRESCRIPCIÓN
  • Get In Touch
  • FAQs
  • Contact Us
  • For US Healthcare Professionals
  • Go To Patient Website
Treatment CentersCoverage Lookup
Tree line, banner

Contact Us

Medical Information Center

Thank you for your interest in contacting Johnson & Johnson Medical Information. Please note that we can only provide information about products marketed within the United States and must refer international inquiries to our affiliates.

If you require immediate assistance or wish to report a side effect or product complaint, Johnson & Johnson Medical Information can be reached by phone at 1-800-526-7736, Monday – Friday 9:00 AM to 8:00 PM Eastern Time.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

For additional information, or to connect with the Medical Information Team, contact us at jnjmedicalconnect.com.

For CQUENCE® order management fulfillment support

Visit CQUENCEPORTAL.com, or call 1-833-276-7337 (1-833-CQORDER), Monday – Friday, 8:00 AM to 8:00 PM Eastern Time.

For MyCARVYKTI® patient support services

To get your patients started, contact a MyCARVYKTI® patient support specialist at 1-800-559-7875, Monday – Friday, 8:00 AM to 8:00 PM Eastern Time.

Get in
Touch

Questions? Ask to be contacted by a CARVYKTI® representative

Contact a Rep

Scroll to Top ↑